Literature DB >> 21896700

Initial recovery and rebound of type f intestinal colonization botulism after administration of investigational heptavalent botulinum antitoxin.

Ryan P Fagan1, Karen P Neil, Randy Sasich, Carolina Luquez, Hakam Asaad, Susan Maslanka, Wajahat Khalil.   

Abstract

Investigational heptavalent botulinum antitoxin (HBAT) is now the primary antitoxin for US noninfant botulism patients. HBAT consists of equine Fab/F(ab')2 IgG fragments, which are cleared from circulation faster than whole immunoglobulins. Rebound botulism after antitoxin administration is not previously documented but occurred in our patient 10 days after HBAT administration.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21896700     DOI： 10.1093/cid/cir550

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  13 in total

1.  Botulism mortality in the USA, 1975-2009.

Authors:  Kelly A Jackson; Barbara E Mahon; John Copeland; Ryan P Fagan
Journal:  Botulinum J       Date:  2016-08-04

2.  A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes.

Authors:  Yongfeng Fan; Consuelo Garcia-Rodriguez; Jianlong Lou; Weihua Wen; Fraser Conrad; Wenwu Zhai; Theresa J Smith; Leonard A Smith; James D Marks
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

3.  A Single Tri-Epitopic Antibody Virtually Recapitulates the Potency of a Combination of Three Monoclonal Antibodies in Neutralization of Botulinum Neurotoxin Serotype A.

Authors:  Jianlong Lou; Weihua Wen; Fraser Conrad; Qi Meng; Jianbo Dong; Zhengda Sun; Consuelo Garcia-Rodriguez; Shauna Farr-Jones; Luisa W Cheng; Thomas D Henderson; Jennifer L Brown; Theresa J Smith; Leonard A Smith; Anthony Cormier; James D Marks
Journal:  Toxins (Basel)       Date:  2018-02-15       Impact factor: 4.546

4.  A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes.

Authors:  Consuelo Garcia-Rodriguez; Ali Razai; Isin N Geren; Jianlong Lou; Fraser Conrad; Wei-Hua Wen; Shauna Farr-Jones; Theresa J Smith; Jennifer L Brown; Janet C Skerry; Leonard A Smith; James D Marks
Journal:  Toxins (Basel)       Date:  2018-03-01       Impact factor: 4.546

5.  Monoclonal Antibody Combinations Prevent Serotype A and Serotype B Inhalational Botulism in a Guinea Pig Model.

Authors:  Milan T Tomic; Yero Espinoza; Zachary Martinez; Khanh Pham; Ronald R Cobb; Doris M Snow; Christopher G Earnhart; Traci Pals; Emily S Syar; Nancy Niemuth; Dean J Kobs; Shauna Farr-Jones; James D Marks
Journal:  Toxins (Basel)       Date:  2019-04-06       Impact factor: 4.546

6.  Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.

Authors:  Yongfeng Fan; Jason R Barash; Jianlong Lou; Fraser Conrad; James D Marks; Stephen S Arnon
Journal:  J Infect Dis       Date:  2016-03-01       Impact factor: 5.226

7.  Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody.

Authors:  Yağmur Derman; Katja Selby; Sebastian Miethe; André Frenzel; Yvonne Liu; Christine Rasetti-Escargueil; Arnaud Avril; Thibaut Pelat; Remi Urbain; Alexandre Fontayne; Philippe Thullier; Dorothea Sesardic; Miia Lindström; Michael Hust; Hannu Korkeala
Journal:  Toxins (Basel)       Date:  2016-09-12       Impact factor: 4.546

Review 8.  The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies.

Authors:  Christine Rasetti-Escargueil; Arnaud Avril; Sebastian Miethe; Christelle Mazuet; Yagmur Derman; Katja Selby; Philippe Thullier; Thibaut Pelat; Remi Urbain; Alexandre Fontayne; Hannu Korkeala; Dorothea Sesardic; Michael Hust; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2017-10-02       Impact factor: 4.546

9.  Adult Intestinal Botulism: A Rare Presentation in an Immunocompromised Patient With Short Bowel Syndrome.

Authors:  Pramod K Guru; Tara L Becker; Alana Stephens; Rocco J Cannistraro; Benjamin H Eidelman; D Jane Hata; Lisa Brumble
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2018-08-03

Review 10.  Antibodies and Vaccines against Botulinum Toxins: Available Measures and Novel Approaches.

Authors:  Christine Rasetti-Escargueil; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2019-09-12       Impact factor: 4.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.